Form 4: Inspire Medical Systems Director Acquires Shares in Lieu of Cash Fees

Sentiment:

SEC Form 4


Director Casey M. Tansey acquired 68 shares of Inspire Medical Systems, Inc. common stock in lieu of cash fees on October 14, 2024.

Summary

  • On October 14, 2024, Casey M. Tansey, a director of Inspire Medical Systems, Inc., acquired 68 shares of common stock.
  • The shares were received in lieu of cash fees, as per the company's Non-Employee Director Compensation Policy.
  • The price per share was $210.46.
  • Following the transaction, Tansey directly owns 20,431 shares.
  • Tansey also indirectly owns 500 shares through The Kimberly Tansey Irrevocable Trust and 500 shares through The Kylie Tansey Irrevocable Trust.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine transaction related to director compensation. The director taking shares instead of cash could be seen as a slightly positive signal.

Positives

  • A director's decision to take shares in lieu of cash may signal confidence in the company's future performance.

Industry Context

This is a routine disclosure related to insider transactions and director compensation, common in publicly traded companies.

Stakeholder Impact

  • The transaction has a minimal direct impact on stakeholders.
  • It may slightly increase shareholder confidence if viewed as a positive signal from a company director.

Key Dates

DateDescription
10/14/2024Date of transaction: Casey M. Tansey acquired 68 shares of common stock.
10/16/2024Date of signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.